domingo, 5 de enero de 2020

A survey of U. S. state insurance commissioners concerning genetic testing and life insurance: Redux at 27. - PubMed - NCBI

A survey of U. S. state insurance commissioners concerning genetic testing and life insurance: Redux at 27. - PubMed - NCBI



 2019 Dec 18. doi: 10.1002/jgc4.1197. [Epub ahead of print]

A survey of U. S. state insurance commissioners concerning genetic testing and life insurance: Redux at 27.

Author information


1
University of Iowa College of Law, University of Iowa, Iowa City, IA, USA.

Abstract

Nearly three decades ago, scientists set out on one of the largest research endeavors in modern history-mapping the human genome. The research not only sparked new technologies and genetic tests, but also concomitant concerns regarding ethical, legal, and social implications of the technologies. These developments ultimately resulted in an expanded role for genetic counselors to educate consumers about the possible consequences of receiving genetic test results. In particular, many individuals undergoing testing worry that the resulting information could be used by social actors, such as life insurers, in harmful ways. Because life insurance is regulated at the state level, there is significant variability across the United States in laws and enforcement protecting consumers' genetic information. This article reports the results of a survey of U.S. state insurance commissioners regarding regulation of genetic testing and life insurance. The survey builds on a 1992 survey conducted by Jean E. McEwen et al. It returns to current U.S. state insurance commissioners to investigate changes in the climate surrounding genetic information use and risks of misuse within the insurance industry. In their 1992 survey, McEwen et al. found that: (a) genetic testing was not yet perceived to pose a significant problem for insurance rating, (b) life insurers had quite a bit of legal freedom to require and use genetic test results, and (c) insurance commissioners had received few consumers' complaints about the use of genetic information. Twenty-seven years later, our survey finds an increase in regulation protecting genetic information in insurance, but at a pace much slower than that of advances in new DNA technologies. This lag in policy to match technology increases potential risks for consumers. Our study further reveals certain inconsistencies in the letter of state law protecting consumers' genetic information and how state insurance commissioners apply that law. The study also shows that despite empirical evidence in the literature demonstrating consumer fear about genetic discrimination, consumers do not report these concerns to their state insurance commissioner. We suggest genetic counselors are key stakeholders who can help fill current gaps between consumers and the insurance industry.

KEYWORDS:

discrimination; ethics; genetic discrimination; genetic testing; insurance commissioners; life insurance; policy

PMID:
 
31850620
 
DOI:
 
10.1002/jgc4.1197

No hay comentarios: